Foosung (093370) Q1 2025 earnings summary

Executive summary

• Q1 2025 consolidated sales reached ₩107.1 billion, down 1.3% year-over-year due to global economic slowdown and weaker demand in downstream industries, especially for battery materials and semiconductor specialty gases.

• Operating loss was ₩0.1 billion, with a net loss of ₩1.9 billion attributable to the parent, reflecting margin pressure and lower sales.

• The company maintains a leading position in fluorochemical products and chemical plant equipment, with ongoing investments in capacity and R&D.

Financial highlights

• Q1 2025 revenue: ₩107.1 billion (down 1.3% YoY); operating loss: ₩0.1 billion; net loss: ₩1.9 billion.

• Gross margin declined due to higher raw material costs and lower utilization rates.

• Cash and equivalents at quarter-end: ₩83.8 billion; total assets: ₩860.7 billion; equity: ₩365.7 billion.

• Q1 2025 R&D expenditure: ₩2.0 billion (3.2% of sales).

Outlook and guidance

• Management expects continued market volatility due to global economic and geopolitical uncertainties.

• Focus remains on expanding global market share in battery materials and specialty gases, and on cost control.

• Ongoing investments in new production lines for LiPF6 and semiconductor gases to support future growth.